RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of VSTM
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for Verastem
(Updated on Mar 28, 2024)

Sell candidate since Mar 14, 2024 Gain 12.38% PDF

The Verastem stock price fell by -0.169% on the last day (Thursday, 28th Mar 2024) from $11.82 to $11.80. During the last trading day the stock fluctuated 3.64% from a day low at $11.68 to a day high of $12.10. The price has risen in 7 of the last 10 days and is up by 12.38% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -69 thousand shares and in total, 98 thousand shares were bought and sold for approximately $1.16 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 16.82% during the next 3 months and, with a 90% probability hold a price between $12.06 and $17.96 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

VSTM Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Verastem stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $12.02. On a fall, the stock will find some support from the short-term average at $11.79. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Tuesday, February 06, 2024, and so far it has fallen -16.13%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Verastem stock

Verastem finds support from accumulated volume at $11.79 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.425 between high and low, or 3.64%. For the last week the stock has had daily average volatility of 4.84%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (VSTM) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Verastem to open at $11.86, and during the day (based on 14 day Average True Range), to move between $11.04 and $12.56, which gives a possible trading interval of +/-$0.764 (+/-6.47%) up or down from last closing price. If Verastem takes out the full calculated possible swing range there will be an estimated 12.95% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $11.79 (0.08%) than the resistance at $11.86 (0.51%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Verastem stock A Buy?

Verastem holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.552 Sell Candidate Unchanged

Predicted Opening Price for Verastem of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$11.86 ( 0.494%) $11.80

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for VSTM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 12.28 4.10 %
R2 12.12 2.72 %
R1 12.02 1.87 %
Current price: 11.80
Support S1 11.70 -0.88 %
S2 11.60 -1.73 %
S3 11.43 -3.11 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 12.45 5.51 %
R2 12.04 2.03 %
R1 11.86 0.508 %
Current price 11.80
Support S1 11.79 -0.0847%
S2 11.74 -0.508%
S3 11.31 -4.15%

FAQ

What is the symbol for Verastem Stock and on which exchange is it traded?
The symbol for Verastem is VSTM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Verastem Stock?
Verastem holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Verastem Stock?
Verastem Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Verastem Stock.

What's the current price of Verastem Stock?
As of the end of day on the 2024-03-28, the price of an Verastem (VSTM) share was $11.80.

What is the 52-week high and low for Verastem Stock?
The 52-week high for Verastem Stock is $15.18 and the 52-week low is $4.20.

What is the market capitalization of Verastem Stock?
As of the 2024-03-28, the market capitalization of Verastem is 293.175M.

When is the next earnings date for Verastem?
The upcoming earnings date for Verastem is May 14, 2024.
Click to get the best stock tips daily for free!

About Verastem

Verastem Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylate MEK. The company also engages in developing RAMP 201, an adaptive two-part multicenter, parallel coho... VSTM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT